1 |
Sperandio FF, Huang YY, Hamblin MR. Antimicrobial photodynamic therapy to kill Gram-negative bacteria. Recent Pat Antiinfect Drug Discov. 2013;8:108-120.
DOI
|
2 |
Baltazar LM, Ray A, Santos DA, et al. Antimicrobial photodynamic therapy: an effective alternative approach to control fungal infections. Front Microbiol. 2015;6:202.
|
3 |
Yoshihara T, Shimanuki T, Araki T, et al. Phleichrome: a new phytotoxic compound produced by Cladosporium phlei. Arg Biol Chem. 1975;39:1683-1684.
|
4 |
So KK, Jo IS, Chae MS, et al. Improved production of phleichrome from the phytopathogenic fungus Cladosporium phlei using synthetic inducers and photodynamic ROS production by phleichrome. J Biosci Bioeng. 2015;119:289-296.
DOI
|
5 |
Gnanamanickam SS, Smith DA. Selective toxicity of isoflavonoid phytoalexins to Gram-positive bacteria. Phytopathology. 1980;70:894-896.
DOI
|
6 |
So Y, Lee SY, Han AR, et al. Rosmarinic acid methyl ester inhibits LPS-induced NO production via suppression of MyD88- dependent and -independent pathways and induction of HO-1 in RAW 264.7 cells. Molecules. 2016;21:1083.
DOI
|
7 |
Zhu TC, Finlay JC. The role of photodynamic therapy (PDT) physics. Med Phys. 2008;35:3127-3136.
DOI
|
8 |
Rkein AM, Ozog DM. Photodynamic therapy. Dermatol Clin. 2014;32:415-425.
DOI
|
9 |
Abrahamse H, Hamblin MR. New photosensitizers for photodynamic therapy. Biochem J. 2016;473:347-364.
DOI
|
10 |
O’Connor AE, Gallagher WM, Byrne AT. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol. 2009;85:1053-1074.
DOI
|
11 |
Alves E, Costa L, Carvalho CM, et al. Charge effect on the photoinactivation of Gram-negative and Gram-positive bacteria by cationic meso-substituted porphyrins. BMC Microbiol. 2009;9:70.
DOI
|
12 |
Merchat M, Spikes JD, Bertoloni G, et al. Studies on the mechanism of bacteria photosensitization by meso-substituted cationic porphyrins. J Photochem Photobiol B Biol. 1996;35:149-157.
DOI
|
13 |
Caminos DA, Spesia MB, Durantini EN. Photodynamic inactivation of Escherichia coli by novel meso-substituted porphyrins by 4-(3-N,N,N-trimethylammoniumpropoxy)phenyl and 4-(trifluoromethyl)phenyl groups. Photochem Photobiol Sci. 2006;5:56-65.
DOI
|
14 |
Banfi S, Caruso E, Buccafurni L, et al. Antibacterial activity of tetraaryl-porphyrin photosensitizers: an in vitro study on Gram negative and Gram positive bacteria. J Photochem Photobiol B. 2006;85:28-38.
DOI
|
15 |
Pra_zmo EJ, Kwasny M, Lapinski M, et al. Photodynamic therapy as a promising method used in the treatment of oral diseases. Adv Clin Exp Med. 2016;25:799-807.
DOI
|
16 |
Masiera N, Bojarska A, Gawryszewska I, et al. Antimicrobial photodynamic therapy by means of porphycene photosensitizers. J Photochem Photobiol B Biol. 2017;174:84-89.
DOI
|
17 |
Ackroyd R, Kelty C, Brown N, et al. The history of photodetection and photodynamic therapy. Photochem Photobiol. 2001;74:656-669.
DOI
|